The group’s principal activities include designing, developing and commercializing of screening systems to assist in the early detection of cancer. The group products include Cocktail-CVX(TM), Cocktail-GCI(TM), AcCell(TM) and AIPS(TM). The group marketed its products under the trade names InPath e2 Collector and Cocktail-CVX. The group operates from the United States.
